Abstract:The idea that a longer duration of untreated psychosis (DUP) leads to poorer outcomes has contributed to extensive changes in mental health services worldwide and has attracted considerable research interest over the past 30 years. However, the strength of the evidence underlying this notion is unclear. To address this issue, we conducted an umbrella review of available meta‐analyses and performed a random‐effects meta‐analysis of primary studies. MEDLINE, Web of Science, PsycINFO and EMBASE were searched from inception to September 3, 2020 to identify relevant meta‐analyses of studies including patients with schizophrenia spectrum disorders, first‐episode psychosis, or affective and non‐affective psychosis. Thirteen meta‐analyses were included, corresponding to 129 individual studies with a total sample size of 25,657 patients. We detected potential violations of statistical assumptions in some of these meta‐analyses. We therefore conducted a new random‐effects meta‐analysis of primary studies. The association between DUP and each outcome was graded according to a standardized classification into convincing, highly suggestive, suggestive, weak, or non‐significant. At first presentation, there was suggestive evidence for a relationship between longer DUP and more severe negative symptoms (beta=–0.07, p=3.6×10–5) and higher chance of previous self‐harm (odds ratio, OR=1.89, p=1.1×10–5). At follow‐up, there was highly suggestive evidence for a relationship between longer DUP and more severe positive symptoms (beta=–0.16, p=4.5×10–8), more severe negative symptoms (beta=–0.11, p=3.5×10–10) and lower chance of remission (OR=2.16, p=3.0×10–10), and suggestive evidence for a relationship between longer DUP and poorer overall functioning (beta=–0.11, p=2.2×10–6) and more severe global psychopathology (beta=–0.16, p=4.7×10–6). Results were unchanged when analysis was restricted to prospective studies. These effect sizes are clinically meaningful, with a DUP of four weeks predicting >20% more severe symptoms at follow‐up relative to a DUP of one week. We conclude that DUP is an important prognostic factor at first presentation and predicts clinically relevant outcomes over the course of illness. We discuss conceptual issues in DUP research and methodological limitations of current evidence, and provide recommendations for future research.

Duration of untreated psychiatry affecting white matter integrity in first-episode medication-free patients with schizophrenia

[An MRI Study of the Relationship Between Duration of Untreated Psychosis and Morphology of Cerebral Cortex in First-episode Schizophrenia].

Duration of Untreated Psychosis is Associated with Temporal and Occipitotemporal Gray Matter Volume Decrease in Treatment Naïve Schizophrenia

Risperidone-induced Topological Alterations of Anatomical Brain Network in First-Episode Drug-Naive Schizophrenia Patients: a Longitudinal Diffusion Tensor Imaging Study

The influence of duration of unmedicated psychosis on the neurocognitive functions of drug-naive and first episode schizophrenia

White Matter Microstructural Abnormalities in Patients with Late-Onset Schizophrenia Identified by a Voxel-Based Diffusion Tensor Imaging

Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia: A 1-year study.

Correlation between duration of untreated psychosis and long-term prognosis in chronic schizophrenia

Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia.

Factors Related to Duration of Untreated Psychosis of First Episode Schizophrenia Spectrum Disorder.

Abnormal White Matter Microstructure in Drug-Naive First Episode Schizophrenia Patients Before and after Eight Weeks of Antipsychotic Treatment.

Duration of untreated illness and its influential factors in schizophrenia

Pretreatment Abnormalities in White Matter Integrity Predict One-Year Clinical Outcome in First Episode Schizophrenia

Duration of untreated psychosis and the related factors among Tibetan patients with schizophrenia in Qing- hai

White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.

The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis

The associations between duration of untreated psychosis, growth factors, and neurocognition in patients with drug-naïve schizophrenia

Duration of Untreated Prodromal Symptoms in a Chinese Sample at a High Risk for Psychosis: Demographic, Clinical, and Outcome

Impact of duration of untreated psychosis in short-term response to treatment and outcome in antipsychotic naïve first-episode psychosis

Short-term Effects of Antipsychotic Treatment on Cerebral Function in Drug-Naive First-Episode Schizophrenia Revealed by “resting State” Functional Magnetic Resonance Imaging

Two Patterns of White Matter Abnormalities in Medication-Naive Patients With First-Episode Schizophrenia Revealed by Diffusion Tensor Imaging and Cluster Analysis.